unknown
Stage
About
Avotres develops therapies targeting autoimmune diseases and cancer, leveraging drug targets to commercialize treatments for these indications.
Explore Avotres's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.